Background The performance of 5D imaging in CHD has been previously demonstrated using ferumoxytol rather than gadolinium.Purpose To evaluate the performance of gadolinium enhanced 5D MRI relative to 2D and 3D MRI in CHD patients.Study Type Retrospective.Subjects 45 consecutive CHD patients referred for clinically indicated MRI who underwent 2D, 3D, and 5D MRI.Field Strength/sequence 2D bSSFP CINE, 3D bSSFP, and 5D FISS at 1.5 T.Assessment Scan time (2D, 3D, and 5D), left and right ventricular (LV, RV) end diastolic and end systolic volumes (LVEDV, RVEDV, LVESV, and RVESV, respectively), ejection fraction (LVEF, RVEF) for 2D versus 5D, and image quality on a 4-point Likert scale (3D vs. 5D).Statistical Tests Paired comparisons were made using a paired t-test or Wilcoxon signed rank test. Agreement between measurements was evaluated with Bland-Altman analysis including the bias and 95% limits of agreement.Results Scan time for 5D (6:18 0) was significantly shorter than 2D (7:16 4:39) and 3D (6:55 1:30) MRI. 5D measurements were strongly correlated with 2D measurements of LVEDV (R2 = 0.94), LVESV (R2 = 0.83), LVEF (R2 = 0.51), (R2 = 0.85), RVESV (R2 = 0.80), and RVEF (R2 = 0.66) but with significant biases. Sharpness of the coronary arteries were significantly higher for 3D (RCA: 36.8% ± 10.2%, LAD: 40.5% ± 10.5%) than 5D (RCA: 24.3% ± 7.5%, LAD: 31.7% ± 8.7%), but longer vessel segments were visible using 5D (LAD: 6.9 ± 2.5) than 3D (LAD: 5.3 ± 2.9 mm) acquisitions. The grades for 5D (R1: 3 1, R2: 2.5 0.5, R3: 3 0.6) were significantly higher than 3D (R1: 3 1, R2: 2.5 1, R3: 2 1).Data Conclusion Gadolinium-enhanced 5D MRI may provide an efficient and simplified acquisition for CHD patients, with multiple quantitative parameters from 5D being not significantly different from those from reference standard 2D and 3D MRI.Evidence Level 4 STAGE OF TECHNICAL EFFICACY: 1.A highly efficient and simplified method for dynamic imaging of the whole heart called five‐dimensional (5D) FISS is presented. This approach uses standard gadolinium contrast rather than previously demonstrated imaging that used off‐label ferumoxytol providing a method that can be more widely disseminated. Comparisons between 5D FISS with reference standard two and three‐dimensional imaging were performed in 45 patients with congenital heart disease. 5D FISS was not significantly different from reference standards across a number of relevant clinical parameters. These findings suggest this approach could simplify and improve cardiac imaging for patients with congenital heart disease.
Roy et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: